LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Clinical trials for LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a common blood pressure pill boost radiation against tough pancreatic tumors?
Disease control OngoingThis early-phase study tests whether adding the blood pressure drug losartan to a shorter, stronger course of radiation can help treat pancreatic cancer that is either hard to remove surgically or has spread locally. Losartan may improve blood flow and oxygen in the tumor, making…
Matched conditions: LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: University of Utah • Aim: Disease control
Last updated May 26, 2026 06:10 UTC
-
Sound waves could supercharge chemo against tough pancreatic cancer
Disease control OngoingThis study tests a new method called sonoporation, which uses ultrasound and tiny gas bubbles to help chemotherapy drugs get into cancer cells more effectively. About 120 adults with advanced pancreatic cancer will receive either standard chemotherapy alone or chemotherapy plus s…
Matched conditions: LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Flemming Forsberg • Aim: Disease control
Last updated May 26, 2026 06:00 UTC
-
Personalized cell therapy trial for advanced cancers withdrawn before enrollment
Disease control TerminatedThis early-stage trial aimed to test the safety and effectiveness of STIL101, a personalized cell therapy made from a patient's own tumor-fighting T cells, for several advanced cancers including pancreatic, colorectal, kidney, cervical, and melanoma. The treatment involved collec…
Matched conditions: LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New combo therapy aims to control hard-to-treat pancreatic cancer
Disease control TerminatedThis early-phase study tests a drug called NBTXR3, which is activated by radiation, in people with pancreatic cancer that is locally advanced or borderline resectable. The goal is to find a safe dose and see if it helps control the disease. About 24 adults will take part, and the…
Matched conditions: LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 18, 2026 12:01 UTC
-
Promising pancreatic cancer study pulled before it began
Knowledge-focused TerminatedThis study aimed to test new therapies for people with pancreatic cancer that hasn't spread. It was designed to compare experimental treatments against standard chemotherapy in three groups based on how far the cancer had grown. However, the study was withdrawn before enrolling a…
Matched conditions: LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 22, 2026 13:55 UTC